Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Carrillo

Showing results (11-20 of 242) with videos related to

Pageof 25
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 26, 2025
Perspective: Emerging challenges for a future ADNIZaven Khachaturian, Maria C Carrillo, Ara S Khachaturian
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discoveryDale Schenk, Maria C Carrillo, John Q Trojanowski
JAMA Neurology|April 21, 2025
IWG and AA Criteria-Where the Differences MatterClifford R Jack, Maria C Carrillo, Reisa A Sperling
Journal of the American Medical Directors Association|October 5, 2015
How Should Cognitive Impairment Be Recognized?Keith N Fargo, Cyndy B Cordell, Maria C Carrillo
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 14, 2009
Maximizing the Alzheimer's Disease Neuroimaging Initiative IIMaria C Carrillo, Charles A Sanders, Russell G Katz
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 6, 2024
The role of the Alzheimer's Association in the genesis of Alzheimer's Disease Neuroimaging InitiativeMaria C Carrillo, Simin Mahinrad, Heather M Snyder, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 10, 2022
Current understanding of AD pathophysiology and impact of amyloid beta-targeted treatments on biomarkers and clinical endpointsRonald C Petersen, Ana Graf, Maria C Carrillo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 28, 2025
What the U.S. POINTER results mean for public health initiatives and the Alzheimer's AssociationMaria C Carrillo, Heather M Snyder, Matthew Baumgart, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 15, 2023
Alzheimer's Targeted Treatments: Focus on Amyloid and InflammationTakeshi Iwatsubo, Michael C Irizarry, Joseph W Lewcock, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2022
Current understanding of AD pathophysiology and impact of amyloid-beta targeted treatments on biomarkers and clinical endpointsRonald C Petersen, Ana Graf, Maria C Carrillo, et al.
Pageof 25

Showing results (11-20 of 242) with videos related to

Sort By:
Pageof 25
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 26, 2025
Perspective: Emerging challenges for a future ADNIZaven Khachaturian, Maria C Carrillo, Ara S Khachaturian
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discoveryDale Schenk, Maria C Carrillo, John Q Trojanowski
JAMA Neurology|April 21, 2025
IWG and AA Criteria-Where the Differences MatterClifford R Jack, Maria C Carrillo, Reisa A Sperling
Journal of the American Medical Directors Association|October 5, 2015
How Should Cognitive Impairment Be Recognized?Keith N Fargo, Cyndy B Cordell, Maria C Carrillo
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 14, 2009
Maximizing the Alzheimer's Disease Neuroimaging Initiative IIMaria C Carrillo, Charles A Sanders, Russell G Katz
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 6, 2024
The role of the Alzheimer's Association in the genesis of Alzheimer's Disease Neuroimaging InitiativeMaria C Carrillo, Simin Mahinrad, Heather M Snyder, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 10, 2022
Current understanding of AD pathophysiology and impact of amyloid beta-targeted treatments on biomarkers and clinical endpointsRonald C Petersen, Ana Graf, Maria C Carrillo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 28, 2025
What the U.S. POINTER results mean for public health initiatives and the Alzheimer's AssociationMaria C Carrillo, Heather M Snyder, Matthew Baumgart, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 15, 2023
Alzheimer's Targeted Treatments: Focus on Amyloid and InflammationTakeshi Iwatsubo, Michael C Irizarry, Joseph W Lewcock, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2022
Current understanding of AD pathophysiology and impact of amyloid-beta targeted treatments on biomarkers and clinical endpointsRonald C Petersen, Ana Graf, Maria C Carrillo, et al.
Pageof 25